What has been updated
The federal Department of Health, Disability and Ageing has amended the rules that govern the Efficient Funding of Chemotherapy Special Arrangement. This arrangement controls how certain chemotherapy drugs are funded under the National Health Act 1953.
The amending instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment (September Update) Instrument 2026, with reference F2026L01142. It was registered on 31 August 2026 and is now in force.
What the amendment does
The changes are contained in Schedule 1 of the instrument and amend the original National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024 (PB 31 of 2024). The source document does not specify the exact nature of the amendments made in this update.
Where to find the full instrument
The complete instrument and its explanatory statement are available on the Federal Register of Legislation at https://www.legislation.gov.au/F2026L01142. The explanatory statement on that page provides a plain-language description of what the September update changes.
Key actions
- Pharmacies and health providers dispensing chemotherapy drugs under the Efficient Funding of Chemotherapy arrangement are required to review the full instrument at https://www.legislation.gov.au/F2026L01142 to identify what has changed in Schedule 1.
- The explanatory statement available on the same legislation page contains a plain-language description of the specific changes made by the September update.
- Bookkeepers and accountants handling billing for health providers using this arrangement are required to confirm with the provider that their claiming processes reflect the updated instrument now that it is in force.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.